ANI PHARMACEUTICALS, INC Number of Reporting Units
ANI PHARMACEUTICALS, INC (ANIP) reported Number of Reporting Units of 3 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC number of reporting units for the quarter ending 2026-03-31 was 3.00 segment, a 0.00% change year-over-year.
- ANI PHARMACEUTICALS, INC number of reporting units for the quarter ending 2025-03-31 was 3.00 segment, a 50.00% increase year-over-year.
- ANI PHARMACEUTICALS, INC number of reporting units for the quarter ending 2024-03-31 was 2.00 segment, a 0.00% change year-over-year.
- ANI PHARMACEUTICALS, INC number of reporting units for the quarter ending 2023-03-31 was 2.00 segment.
- ANI PHARMACEUTICALS, INC number of reporting units for fiscal 2025 was 3.00 segment, a 0.00% change from fiscal 2024.
- ANI PHARMACEUTICALS, INC number of reporting units for fiscal 2024 was 3.00 segment.
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 6 month | Number of Reporting Units 9 month | Number of Reporting Units 12 month |
|---|---|---|---|---|
| 2026-06-30 | 3.00 segment 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 3.00 segment 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | 3.00 segment 10-K · filed 2026-02-27 | |||
| 2025-09-30 | 3.00 segment 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | 3.00 segment 10-Q · filed 2025-08-08 | |||
| 2025-03-31 | 3.00 segment 10-Q · filed 2025-05-09 | |||
| 2024-12-31 | 3.00 segment 10-K · filed 2025-02-28 | |||
| 2024-09-30 | 2.00 segment 10-Q · filed 2024-11-08 | |||
| 2024-06-30 | 2.00 segment 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | 2.00 segment 10-Q · filed 2024-05-10 | |||
| 2023-09-30 | 2.00 segment 10-Q · filed 2023-11-08 | |||
| 2023-06-30 | 2.00 segment 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | 2.00 segment 10-Q · filed 2023-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |